Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve

Berg, M.H. van den; Overbeek, A.; Lambalk, C.B.; Kaspers, G.J.L.; Bresters, D.; Heuvel-Eibrink, M.M. van den; ... ; DCOG LATER-VEVO Study Grp (2018)

Article / Letter to editor

• childhood cancer survivors
• AMH
• FSH
• inhibin B
• antral follicle count
• ovarian reserve
• chemotherapeutic agents
• radiotherapy

• All authors: Berg, M.H. van den; Overbeek, A.; Lambalk, C.B.; Kaspers, G.J.L.; Bresters, D.; Heuvel-Eibrink, M.M. van den; Kremer, L.C.; Loonen, J.J.; Pal, H.J. van der; Ronckers, C.M.; Tissing, W.J.E.; Versluys, A.B.; Heiden-van der Loo, M. van der; Heijboer, A.C.; Hauptmann, M.; Twisk, J.W.R.; Laven, J.S.E.; Beerendonk, C.C.M.; Leeuwen, F.E. van; Dulmen-den Broeder, E. van; DCOG LATER-VEVO Study Grp
• Date: 2018-08-31
• Journal: Human Reproduction
• Volume: 33
• Issue: 8
• Pages: 1474 - 1488
• DOI: doi:10.1093/humrep/dey229